检索

期
标题
作者
卷 25, 编号 1 (2023)
Diagnostic significance of CA-62 cancer antigen for early detection and differential diagnosis of non-small cell lung cancer: results of the blind clinical trials
Tcherkassova J., Prostyakova A., Tsurkan S., Suganov N., Boroda A., Zhilenkova A., Pirogova J., Sangadzhieva Z., Rusanov A., Rozhkov A., Fatyanova A., Nikitina N., Bagmet N., Sekacheva M.
PDF
(Rus)
卷 24, 编号 1 (2022)
Osimertinib and routine practice: the experience of the drug application in different clinical situations in case of metastatic non-small cell lung cancer with an EGFR mutation. Case report
Orlov S., Baldin P., Diuzeva N., Krechetova A., Mordovskiy A., Moskovchenko A., Musaeva N., Romanchuk O.
PDF
(Rus)
卷 24, 编号 1 (2022)
Atezolizumab in the first-line treatment of metastatic non-small cell lung cancer. Clinical experience of the drug application. Case report
Ognerubov N., Antipova T.
PDF
(Rus)
卷 23, 编号 4 (2021)
Targeted therapy of brain metastases in patients with ALK-positive non-small cell lung cancer: A review
Sakaeva D., Bulavina I.
PDF
(Rus)
卷 16, 编号 3 (2014)
Avastin in clinical chemotherapy of malignant tumors
Gorbunova V.
卷 20, 编号 3 (2018)
Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo
Novikov D., Polotskiy B., Bogush T., Davidov M., Ahmedov B., Rotobelskaya L.
PDF
(Rus)
卷 15, 编号 1 (2013)
Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
Kit O., Vladimirova L., Sholokhova E.
卷 21, 编号 3 (2019)
Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer
Reutova E., Laktionov K., Iudin D., Neliubina L., Gorokhova G., Egorova A.
PDF
(Rus)
卷 23, 编号 3 (2021)
Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives
Yudin D., Laktionov K., Laktionova L., Breder V.
PDF
(Rus)
卷 22, 编号 2 (2020)
Adjuvant targeted therapy for non-small cell lung cancer
Laktionov K., Kazakov A., Gordiev M., Kononets P., Akhmedov B., Maevskaia J.
PDF
(Rus)
卷 23, 编号 3 (2021)
Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: new features
Reutova E., Laktionov K.
PDF
(Rus)
卷 20, 编号 3 (2018)
The evolution of views on the possibilities of drug therapy in overcoming acquired resistance not associated with Т790М mutation to anti-EGFR drugs in non-small cell lung cancer
Karabina E., Lubchenko L., Garunov A.
PDF
(Rus)
卷 22, 编号 3 (2020)
Detection of disseminated tumor cells and their relationship with a population of bone marrow lymphocytes in patients with non-small cell lung cancer
Djumanazarov T., Chulkova S., Tupitsyn N., Chernysheva O., Allakhverdiev A., Palladina A., Kupryshina N., Kolbatskaya O., Kononetz P., Akhmedov B., Gerasimov S.
PDF
(Rus)
卷 19, 编号 2 (2017)
The treatment of patients with advanced lung cancer associated with EGFR mutation
Bolotina L.
PDF
(Rus)
卷 22, 编号 3 (2020)
Molecular genetic portrait of non-small cell lung cancer in Tambov region: regional experience
Ognerubov N., Sychev V., Kozlova N., Chang V.
PDF
(Rus)
卷 19, 编号 1 (2017)
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor
Ryazhenov V.
PDF
(Rus)
卷 22, 编号 3 (2020)
Prospects for the development of adjuvant therapy for non-small cell lung cancer
Laktionov K., Kazakov A., Reutova E., Ardzinba M., Arzumanian A.
PDF
(Rus)
卷 18, 编号 3 (2016)
Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene
Ryazhenov V., Gorokhova S.
PDF
(Rus)
卷 22, 编号 2 (2020)
Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma
Odintsova S., Sviridenko M., Cheremnykh A., Filippova E., Urtenova M., Orlov S.
PDF
(Rus)
1 - 19 的 19 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##